“…Subsequently the four mentioned published studies and one ongoing study ( Angst et al, 2020 ;Fredskild et al, 2019Fredskild et al, , 2020Gordon-Smith et al, 2017 ;Machado-Vieira et al, 2017 ) have investigated the prevalence of bipolar disorder according to DSM-5 versus DSM-IV or ICD-10 criteria, but further studies are greatly needed. Thus, further studies are needed within the sixth mentioned validation areas: 1) Clinical presentation according to DSM-5 versus DSM-IV/ICD-10, 2) Associations of the phenotype with paraclinical data such as brain imaging and blood-based data, 3) Delimitation from other disorders, specifically schizophrenia, schizoaffective disorder, depressive disorder, personality disorders, 4) Pathogenesis -associations to family history / genetics and environmental stressors, 5) Prognosis, specifically in relation to implications for diagnostic delay and early intervention as well as long-term diagnostic stability ( Kessing, 2005 ;Kessing et al, 2015 ;Laursen et al, 2020 ), 6) Medical treatment effects of lithium and other mood stabilizers. At some point, the official classification systems will need to incorporate information from sources other than symptoms, and this may come not only from genetic, neuroimaging, and biomarker data, but also from the increasing use of digital markers, in the frame of so-called precision psychiatry Salagre et al, 2018 ).…”